Updating the Adherence–Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Cisgender Women is a research paper published in Clinical Infectious Diseases (2023). On theSindex it has a DataRank of 0.546. It has been cited 37 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.546
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: R01 AI122298
NIAID NIH HHS
Grant: UM1 AI068613
NIAID NIH HHS
Grant: P30 AI094189
NIAID NIH HHS
Grant: R01 AI143357
National Institutes of Health
Grant: 5R01AI143357-03
Statistical methods for clinical trials of novel PrEP agents
National Institutes of Health
Grant: 5R01AI122298-03
Novel approaches for quantitative assessment of adherence
National Institutes of Health
Grant: 5UM1AI068613-16
LC: HIV PREVENTION TRIALS NETWORK
National Institutes of Health
FWCI
6.30
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals